Clinical QA Specialist
Elucid
Summary
As a Clinical Quality Assurance Specialist, you'll play a key role in ensuring our cardiovascular imaging software is built to the highest standards of safety, reliability, and clinical precision. You'll design and execute test strategies across the software development lifecycle, meticulously document defects, and collaborate with Software Development, Software QA, Clinical, and Regulatory teams to resolve issues and keep our products compliant.
Job description
The ideal candidate will have:
- A degree in Computer Science, Bioengineering, Biomedical Engineering or a related field, or equivalent relevant work experience
- 2+ years of clinical software quality assurance or medical device software testing, including hands-on functional testing
- Excellent written and verbal communication skills, with a track record of collaborating closely with software development and software QA teams
- The adaptability to thrive in a fast-paced startup environment with evolving priorities
- Strong experience with project management tools like Jira
- Familiarity with medical imaging (CTA), cardiovascular diagnostics, or cardiovascular disease and anatomy is strongly preferred
Work Location:
This is a on-site role based out of our office in Boston, MA
Requirements
- A degree in Computer Science, Bioengineering, Biomedical Engineering or a related field, or equivalent relevant work experience
- 2+ years of clinical software quality assurance or medical device software testing, including hands-on functional testing
- Excellent written and verbal communication skills, with a track record of collaborating closely with software development and software QA teams
- The adaptability to thrive in a fast-paced startup environment with evolving priorities
- Strong experience with project management tools like Jira
- Familiarity with medical imaging (CTA), cardiovascular diagnostics, or cardiovascular disease and anatomy is strongly preferred
Company overview
Elucid is a Boston-based medical technology company founded in 2013 that specializes in developing AI-powered imaging analysis software for cardiovascular disease assessment. The company's flagship product, PlaqueIQ, is the only FDA-cleared computed tomography angiography (CTA) algorithm that objectively quantifies plaque morphology validated against tens of thousands of tissue annotations by renowned pathologists. Elucid's technology brings precision patient care from oncology to cardiology by providing physicians with critical information for assessing the risk of plaque rupture in arteries that can lead to heart attack and stroke. The company's software is designed to understand the root cause of cardiovascular disease deeply, offering objective and quantitative assessment of arterial plaque validated by histology. Elucid has raised over $150 million in funding and is pursuing an indication for FFRCT (fractional flow reserve derived from CT), uniquely derived from its PlaqueIQ technology, to measure coronary blockages non-invasively. The company's solutions are available for commercial use in the U.S., UK, EU, and South Korea, and recently gained broad CMS reimbursement for coronary plaque analysis using PlaqueIQ.